Skip to content
Recall Observatory FDA recall evidence

Drug product

Memantine Hydrochloride Extended Release Capsules, 21 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States. Manufactured by: Lupin Limited Pithampur (M.P.)-454 775, INDIA, NDC 68180-248-06

D-0855-2020

February 12, 2020

Class II

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 84948
Status
Terminated
Classification
Class II
Quantity
6,294 bottles
Official record key
drug-enforcement:D-0855-2020

Official wording

Reason: Failed Dissolution Specifications: Low out of specification results observed in dissolution test at six-month long-term stability study.

Code information: Lot #: H900330, exp. date 11/2020.

Distribution pattern: Nationwide within the United States.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification